CVP, CFO of Edwards Lifesciences Corp (30-Year Financial, Insider Trades) Scott B. Ullem (insider trades) sold 26,700 shares of EW on 08/06/2020 at an average price of $77.31 a share. The total sale was $2.1 million.
Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards Lifesciences Corp has a market cap of $48.13 billion; its shares were traded at around $77.41 with a P/E ratio of 66.55 and P/S ratio of 11.35. Edwards Lifesciences Corp had annual average EBITDA growth of 16.30% over the past ten years. GuruFocus rated Edwards Lifesciences Corp the business predictability rank of 3-star. GuruFocus has detected 1 severe warning sign with Edwards Lifesciences Corp. .
CEO Recent Trades:
- Chairman & CEO Michael A Mussallem sold 68,550 shares of EW stock on 07/09/2020 at the average price of $68.22. The price of the stock has increased by 13.47% since.
CFO Recent Trades:
- CVP, CFO Scott B. Ullem sold 26,700 shares of EW stock on 08/06/2020 at the average price of $77.31. The price of the stock has increased by 0.13% since.
Directors and Officers Recent Trades:
- CVP, TAVR Larry L Wood sold 10,698 shares of EW stock on 08/03/2020 at the average price of $78.4. The price of the stock has decreased by 1.26% since.
- CVP, Critical Care Catherine M. Szyman sold 2,249 shares of EW stock on 07/14/2020 at the average price of $67.66. The price of the stock has increased by 14.41% since.
- CVP, Japan & Intercontinental Huimin Wang sold 11,649 shares of EW stock on 07/10/2020 at the average price of $67.46. The price of the stock has increased by 14.75% since.
- CVP,Strategy/Corp Development Donald E Jr Bobo sold 13,074 shares of EW stock on 07/10/2020 at the average price of $67.46. The price of the stock has increased by 14.75% since.
For the complete insider trading history of EW, click here
.
